CLINICAL SERVICE


The Division comprises teams of experts in benign and malignant blood diseases, bone marrow transplantation and medical oncology. About 1000 new cases of these diseases are referred annually. The majority of these patients have haematological malignancies, consisting of acute and chronic leukaemias, lymphomas, plasma cell myeloma and other haematological neoplasms. Patients with other benign blood diseases including coagulation and bleeding disorders, acquired and inherited anaemias, and platelet disorders are also treated. The major facility for these patients is a specially designed haematology ward with HEPA-filtered air, which accommodates more than twenty patients.

The Division manages an adult haematopoietic stem cell transplantation suite, where more than a hundred allogeneic or autologous transplantations are performed every year. For allogeneic transplantation, this facility is the only one in Hong Kong. The full range of allogeneic transplantation is performed, with haematopoietic stem cells coming from HLA-identical siblings, matched unrelated donors and umbilical cord blood. Autologous transplantations are mainly performed for lymphomas and myeloma. The transplantation suite contains ten single rooms, a cytapheresis facility for isolation of peripheral blood haematopoietic stem cells, and a transplantation laboratory.

Medical Oncology is a new development in the Division. Patients with a wide range of solid tumors are treated. Special emphasis has been placed on breast, liver and gastrointestinal cancers.

Specialist Outpatient Clinics

Patient referrals are seen in specialist outpatient clinics, which are listed below. Both Hong Kong residents and foreign patients are welcome. Private patients are also welcome, and appointments can be obtained from the Private Clinic at Queen Mary Hospital. Private patients can be admitted into specially designed private wards at Queen Mary Hospital, which include first class (single room) and second class (double room) suites.

Clinic Day Time Location
Myeloma Monday 9:00 a.m. S6-QMH
HSCT (BMT) Monday 9:00 a.m. C6A-QMH
Lymphoma Monday 9:00 a.m. S3-QMH
GI Oncology Tuesday 9:00 a.m. S6-QMH
Pre-BMT assessment Tuesday 9:00 a.m. K4-QMH
Leukaemia Tuesday 2:00 p.m. S7-QMH
Oncology 3 Tuesday 2:00 p.m. S7-QMH
Anti-coagulation Tuesday 2:00 p.m. C6-QMH
Oncology Wednesday 9:00 a.m. S3-QMH
Blood (HAE) Wednesday 2:00 p.m. S6-QMH
FAM CON Wednesday 2:00 p.m. K4-QMH
Oncology Wednesday 2:00 p.m. S4-QMH
Oncology Thursday 9:00 a.m. S3-QMH
Lymphoma Thursday 9:00 a.m. S3-QMH
HSCT (BMT) Thursday 9:00 a.m. K4-QMH
Haem (MDS/MPN) Thursday 2:00 p.m. S3-QMH
Hepato-Haematology Clinic Friday 9:00 a.m. S7-QMH
Oncology Friday 9:00 a.m. S6-QMH
Combined Haematology – Obstetric Clinic Friday 9:00 a.m. S5-QMH
Anaemia and Bleeding Disorder Friday 9:00 a.m. S6-QMH
Pre-BMT assessment Friday 9:00 a.m. K4-QMH